FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | .75 g/250 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-015 | 71506-015-58 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | 1.5 g/500 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-020 | 71506-020-56 | Calcium Gluconate | 1 g/100 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-021 | 71506-021-56 | Calcium Gluconate | 2 g/100 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-022 | 71506-022-35 | Ephedrine | 15 mg/3 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0335 | 71283-0335-3 | Folic Acid | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1020 | 71283-1020-1 | Hydromorphone Hydrochloride | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0339 | 71283-0339-3 | Hydroxocobalamin | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0532 | 71283-0532-5 | Hydroxyprogesterone Caproate | 250 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1011 | 71283-1011-5 | Lidocaine | 40 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0990 | 71283-0990-6 | Lidocaine Hydrochloride; Hyaluronic Acid | 10 mg/1 mL; 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0990 | 71283-0990-2 | Lidocaine Hydrochloride; Hyaluronic Acid | 10 mg/1 mL; 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0225 | 71283-0225-5 | Magnesium Chloride | 200 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0533 | 71283-0533-5 | "gonadotrophin, Chorionic" | 1000 U/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0534 | 71283-0534-2 | Medroxyprogesterone Acetate | 150 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0333 | 71283-0333-3 | Methylcobalamin | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0332 | 71283-0332-3 | Methylcobalamin | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0331 | 71283-0331-3 | Methylcobalamin | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0619 | 71283-0619-1 | Methylprednisolone | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0626 | 71283-0626-2 | Methylprednisolone Acetate | 80 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0636 | 71283-0636-1 | Methylprednisolone Acetate | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0625 | 71283-0625-2 | Methylprednisolone Acetate | 40 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0623 | 71283-0623-1 | Methylprednisolone Acetate; Bupivacaine Hydrochloride | 40 mg/1 mL; 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0624 | 71283-0624-1 | Methylprednisolone; Bupivacaine Hydrochloride | 80 mg/1 mL; 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0812 | 71283-0812-8 | Mitomycin | 40 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1021 | 71283-1021-1 | Morphine Sulfate | 62.5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0621 | 71283-0621-5 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 4 mg/1 mL; 3 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0620 | 71283-0620-2 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 3 mg/1 mL; 3 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0241 | 71283-0241-5 | Nandrolone Decanoate | 200 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0545 | 71283-0545-2 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 20 ug/1 mL; 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0547 | 71283-0547-2 | Papaverine Hydrochloride; Atropine Sulfate; Phentolamine Mesylate; Alprostadil | 1.8 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 18 ug/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0540 | 71283-0540-5 | Papaverine Hydrochloride; Phentolamine | 30 mg/1 mL; 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0544 | 71283-0544-2 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 1 mg/1 mL; 10 ug/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0550 | 71283-0550-2 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; 60 ug/1 mL; .15 mg/1 mL; 30 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0220 | 71283-0220-3 | Biotin | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1010 | 71283-1010-1 | Bupivacaine | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0530 | 71283-0530-1 | Testosterone Cypionate | 200 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0531 | 71283-0531-1 | Testosterone; Progesterone | 200 mg/1 mL; 2.5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0666 | 71283-0666-2 | Triamcinolone Acetonide | 40 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0633 | 71283-0633-1 | Triamcinolone Acetonide | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0632 | 71283-0632-1 | Triamcinolone Acetonide; Bupivacaine Hydrochloride | 40 mg/1 mL; 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0628 | 71283-0628-2 | Triamcinolone Diacetate | 40 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0627 | 71283-0627-1 | Triamcinolone Diacetate | 40 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0224 | 71283-0224-3 | Zinc Chloride | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0210 | 71283-0210-3 | Cholecalciferol | 1000 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0251 | 71283-0251-3 | Cholecalciferol | 100000 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0420 | 71283-0420-1 | Clonidine Hydrochloride | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0642 | 71283-0642-1 | Dexamethasone Sodium Phosphate | 24 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1012 | 71283-1012-5 | Dimethyl Sulfoxide; Lidocaine Hydrochloride | 550 mg/1 mL; 5 mg/1 mL | 2019-1 | valid | 2026-11-14 |